Literature DB >> 32014626

Meta-analysis of olfactory dysfunction in 22q11.2 deletion syndrome.

Paul J Moberg1, Bruce I Turetsky2, Emily A Moberg3, Christian G Kohler2, Sunny X Tang2, Ruben C Gur4, Raquel E Gur4, David R Roalf4.   

Abstract

A quantitative review of literature concerning olfactory function in 22q11.2 deletion syndrome (22q11DS) patients was performed detailing the scope/magnitude of deficits and probing possible moderators. We searched MEDLINE, EMBASE and PubMed to identify studies for inclusion. Effect sizes were based on differences in psychophysical olfactory tests between 22q11DS patients (n = 194) and typically developing comparison subjects (n = 466). 22q11DS patients exhibited marked olfactory dysfunction (d=-1.11, 95% CI=-1.29<δ<-0.92) that was homogeneous (p = 0.86). Diffuse olfactory deficits were seen which were not moderated by age or sex. 22q11DS patients exhibit large/diffuse deficits in olfactory function that are of a similar magnitude to observed neuropsychological impairments.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  22q11.2 Deletion Syndrome; DiGeorge Syndrome; Meta-analysis; Olfactory; Smell

Year:  2020        PMID: 32014626     DOI: 10.1016/j.psychres.2020.112783

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  2 in total

Review 1.  Pathways to understanding psychosis through rare - 22q11.2DS - and common variants.

Authors:  Raquel E Gur; David R Roalf; Aaron Alexander-Bloch; Donna M McDonald-McGinn; Ruben C Gur
Journal:  Curr Opin Genet Dev       Date:  2021-02-08       Impact factor: 5.578

2.  Ocular findings in 22q11.2 deletion syndrome: A systematic literature review and results of a Dutch multicenter study.

Authors:  Emma N M M von Scheibler; Emy S van der Valk Bouman; Myrthe A Nuijts; Noël J C Bauer; Tos T J M Berendschot; Pit Vermeltfoort; Levinus A Bok; Agnies M van Eeghen; Michiel L Houben; Thérèse A M J van Amelsvoort; Erik Boot; Michelle B van Egmond-Ebbeling
Journal:  Am J Med Genet A       Date:  2021-11-12       Impact factor: 2.578

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.